or Try an Advanced Search...

    Clinical Trial Product Stocks List

    Symbol Grade Name % Change
    HCM A Hutchison China MediTech Limited 0.00
    LBPH B Longboard Pharmaceuticals, Inc. 0.00
    LGND B Ligand Pharmaceuticals Incorporated 0.00
    HALO C Halozyme Therapeutics, Inc. 0.00
    SUPN D Supernus Pharmaceuticals, Inc. 0.00
    INCY F Incyte Corporation 0.00
    BIIB F Biogen Idec Inc. 0.00
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Biopharmaceutical Biotechnology Solid Tumors Alzheimer's Disease Chemical Compounds Chronic Lymphocytic Leukemia Clinical Trial Clinical Trial Products Drug Discovery Epilepsy Lymphocytic Leukemia Monoclonal Antibodies Nasdaq 100 Neurology Organic Compounds Pain Pharmaceutical Psoriasis S&P 500 Amyotrophic Lateral Sclerosis

    Related ETFs - A few ETFs which own one or more of the above listed Clinical Trial Product stocks.

    Symbol Grade Name Weight
    PJP C PowerShares Dynamic Pharmaceuticals 10.98
    FBT D First Trust Amex Biotech Index Fund 9.64
    BIS B ProShares UltraShort Nasdaq Biotechnology 9.05
    IBRN D iShares Neuroscience and Healthcare ETF 8.51
    PBE D PowerShares Dynamic Biotech & Genome 7.82
    View all Clinical Trial Product ETFs...
    Compare ETFs
    Compare IBRN to PBE Compare PJP to IBRN Compare PJP to PBE

        Clinical Trial Product Stocks Recent News

        Date Stock Title
        Apr 24 BIIB Biogen Non-GAAP EPS of $3.67 beats by $0.21, revenue of $2.29B misses by $30M
        Apr 24 BIIB Biogen beats quarterly profit estimates, Alzheimer's drug sales jump
        Apr 24 BIIB Two Notable Biogen Drugs Walloped Sales Forecasts. Will It Be Enough To Reverse Biogen Stock's Decline?
        Apr 24 BIIB Nasdaq Futures Get A Lift From Tesla, Texas Instruments Earnings: Analyst Points To Key Catalyst For Boosting Rally
        Apr 23 INCY Incyte Should Consider Significant Stock Buyback And Prioritize R&D, Analyst Recommends
        Apr 23 BIIB Biogen Q1 2024 Earnings Preview
        Apr 23 INCY Incyte (INCY) Earnings Expected to Grow: Should You Buy?
        Apr 23 INCY Incyte (INCY) to Report Q1 Earnings: What's in the Cards?
        Apr 23 HALO Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
        Apr 23 LGND Ligand to Report First Quarter 2024 Financial Results on May 7, 2024
        Apr 23 HALO Halozyme to Report First Quarter 2024 Financial and Operating Results
        Apr 23 INCY Incyte to acquire immune-focused drug developer Escient
        Apr 23 INCY Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists
        Apr 23 BIIB Should You Be Confident in Biogen (BIIB)?
        Apr 21 BIIB Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
        Apr 19 BIIB What's in Store for Biogen (BIIB) This Earnings Season?
        Apr 19 BIIB Gear Up for Biogen (BIIB) Q1 Earnings: Wall Street Estimates for Key Metrics
        Apr 18 HALO Halozyme Therapeutics (HALO) is an Incredible Growth Stock: 3 Reasons Why
        Apr 18 HALO Halozyme Therapeutics (HALO) Upgraded to Buy: Here's What You Should Know
        Apr 18 BIIB Analysts Estimate Gilead Sciences (GILD) to Report a Decline in Earnings: What to Look Out for
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Biopharmaceutical Biotechnology Solid Tumors Alzheimer's Disease Chemical Compounds Chronic Lymphocytic Leukemia Clinical Trial Clinical Trial Products Drug Discovery Epilepsy Lymphocytic Leukemia Monoclonal Antibodies Nasdaq 100 Neurology Organic Compounds Pain Pharmaceutical Psoriasis S&P 500 Amyotrophic Lateral Sclerosis
        Clinical Trial Product

        Clinical trial product is any material used in a clinical trial, including drugs, medical devices, biologics, and other products. Clinical trial products are used to test the safety and efficacy of a new treatment or medical device. Clinical trial products must meet strict regulatory requirements and be approved by the relevant regulatory authorities before they can be used in clinical trials.

        Browse All Tags